Press release, 21 December 2021 at 9:00 a.m. (EET)
Shin-Oyama City Hospital in Japan has started to sell the preventative health service provided by Nightingale Health Japan KK, a fully owned subsidiary of Nightingale Health Plc (together “Nightingale”), together with Welltus Inc., a subsidiary of Japanese conglomerate Mitsui & Co Ltd..
Nightingale’s preventative health service provides unique data about the customer’s current health status and future health risks. The user of the service receives an individual health score and health measurements describing different health areas, such as heart age, fatty acid balance, inflammation and cholesterol balance. The service also provides recommendations on improving health and wellbeing, and customers can easily track their progress with follow-up tests.
Having the service as part of Shin-Oyama City Hospital’s offering is an important milestone for Nightingale, as the implementation of the commercialization plan in Japan moves from pilot phase towards commercial partnerships. Nightingale and Welltus aim to expand the availability of the service to several hospitals and clinics in Japan during the first half of 2022.
Teemu Suna, CEO and Co-founder of Nightingale:
“Shin-Oyama City hospital is a distinguished hospital with an established customer base for preventative health services. We believe Nightingale’s service brings a valuable addition to Shin-Oyama’s offering, as it combines information of current health status and future health risks with actionable recommendations empowering customers to take actions towards a healthier life – we can also show the impact of these actions in a very powerful way.”
Dr. Masahiro Nakano, Director of Preventive Medical Center at Shin-Oyama City Hospital:
“Shin-Oyama City hospital is very pleased to start offering Nightingale’s preventative health check-up service, as the service captures most relevant lifestyle related disease risks from one blood sample and presents the health information in an easy-to-understand way. The Nightingale health score included in the service is a concrete indicator of overall health and the results show personalized information on which lifestyle changes are worth taking to improve health and wellbeing.”
For further information, please contact:
Teemu Suna, CEO
Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. Our wide-ranging disease risk predictions consist of two interconnected factors: Our proprietary blood analysis technology and a large amount of data on health events. We help people make better personal health decisions and connect the health industry to offer their services for individuals’ preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone.
About Shin-Oyama City Hospital
Shin-Oyama City Hospital was established in 1946. Its Preventive Medical Center aims to prevent the risk of developing age-related diseases such as arteriosclerosis and cancer, as well as lifestyle-related diseases, and to "enjoy a long and healthy life”, from the anti-aging medicine perspective. And the Center provides a variety of medical checkup courses based on the concept of anti-aging of blood vessels.
Mitsui is one of the most diversified and comprehensive trading, investment and service enterprises in the world, with 130 offices in 63 countries as of September, 2021, and revenue of 72.2 billion USD as of March 2021. Utilizing its global operating locations, network and information resources, Mitsui is multilaterally pursuing business that ranges from product sales, worldwide logistics and financing, through to the development of major international infrastructure and other projects in the following fields: Wellness, Iron & Steel Products, Mineral & Metal Resources, Infrastructure Projects, Mobility, Chemicals, Energy, Food, Food & Retail Management, IT & Communication Business, Corporate Development Business. Mitsui is actively taking on challenges for global business innovation around the world.
Welltus is a subsidiary company newly established by Mitsui to deliver science-based analysis and solutions to improve health outcomes. The Company leverages Nightingale’s innovative blood test service and customer-friendly way of visualizing health conditions to help people change their long-term habits and thereby live healthier lives. The Company also utilizes Mitsui’s wide range of network and business portfolio especially in health-care and wellness space to create synergy and expand its service rapidly. In April 2021, Welltus and Nightingale announced a service agreement, based on which the parties will launch several new health and well-being services in Japan. Since June 2021, the first service has been piloted in a few selected medical clinics that sell preventative health check-ups to consumers.